BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 14, Issue 10
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (4339)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-1) series.
Item 
Count 
PDF147
WORD35
HTML1542
Figures (1-5)222
Tables (1-1)204
 Sum=2150
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse200
Download598
 Sum=798
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse312
Download1079
 Sum=1391
Oct 15, 2022 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Li CH, Chen ZM, Chen PF, Meng L, Sui WN, Ying SC, Xu AM, Han WX. Interleukin-34 promotes the proliferation and epithelial-mesenchymal transition of gastric cancer cells. World J Gastrointest Oncol 2022; 14(10): 1968-1980 [PMID: 36310707 DOI: 10.4251/wjgo.v14.i10.1968]
URL: https://www.wjgnet.com/1948-5204/full/v14/i10/1968.htm
Number Citing Articles
1
Giovanni Monteleone, Eleonora Franzè, Claudia Maresca, Marco Colella, Teresa Pacifico, Carmine Stolfi. Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance. Cancers 2023; 15(3): 971 doi: 10.3390/cancers15030971
2
Taozhi Deng, Ping Zhong, Runlong Lou, Xiaojun Yang. RNF220 promotes gastric cancer growth and stemness via modulating the USP22/wnt/β-catenin pathway. Tissue and Cell 2023; 83: 102123 doi: 10.1016/j.tice.2023.102123
3
Nanumi Han, Haruka Wada, Takuto Kobayashi, Ryo Otsuka, Ken-Ichiro Seino. A mechanism of IL-34-induced resistance against cytotoxic anti-cancer therapies such as radiation by X-ray and chemotherapy by Oxaliplatin. OncoImmunology 2023; 12(1) doi: 10.1080/2162402X.2023.2238499
4
Eisa Sabouni, Melina Maghsodlou Nejad, Sarah Mojtabavi, Sara Khoshdooz, Mahsa Mojtabavi, Niloufar Nadafzadeh, Negin Nikpanjeh, Sepideh Mirzaei, Mehrdad Hashemi, Amir Reza Aref, Ramin Khorrami, Noushin Nabavi, Yavuz Nuri Ertas, Shokooh Salimimoghadam, Mohammad Arad Zandieh, Parham Rahmanian, Afshin Taheriazam, Kiavash Hushmandi. Unraveling the function of epithelial-mesenchymal transition (EMT) in colorectal cancer: Metastasis, therapy response, and revisiting molecular pathways. Biomedicine & Pharmacotherapy 2023; 160: 114395 doi: 10.1016/j.biopha.2023.114395
5
Chuan-Hong Li, Zhang-Ming Chen, Pei-Feng Chen, Lei Meng, Wan-Nian Sui, Song-Cheng Ying, A-Man Xu, Wen-Xiu Han. Correction to “Interleukin-34 promotes the proliferation and epithelial-mesenchymal transition of gastric cancer cells”. World Journal of Gastrointestinal Oncology 2023; 15(9): 1673-1674 doi: 10.4251/wjgo.v15.i9.1673
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345